Interested in Next Generation of Kinase Inhibitors, Integrated Drug Discovery partner or services using our technological platforms?

Discovery on Target – 25-28 Septembre – Boston - USA

Oncodesign is pleased to be a sponsor of this major scientific event.

Come & meet Alexis Denis, Head of Discovery Division, Fabrice Viviani, Head of the Experimentation Division & Phil Kasprzyk -  Business Account Manager of North American Operationsat at our booth #211 & during our talk!

TALK – “Integrated Drug Discovery Engine for the Development of the Next-Generation Kinase Inhibitors”
Alexis Denis, PhD, Head of Discovery Division, Oncodesign

Thursday, 27 September, 3:55pm

I read the l'abstract!

Join us at the EurOPDX Workshop for great talks and discussions on all aspects of patient-derived xenograft tumor research!

EurOPDX Workshop – 1-3 Octobre– Weggis – Suisse

Don’t miss the latest results presented in our poster about Oncodesign’s work on tailored rodent models such as humanized models available for the investigation of the mechanism of action of your immuno-oncology therapies.

POSTER – “How PDX models could help the development of immuno-oncology therapies?”
Caroline Mignard, PhD, Study Director, Oncodesign

I read the abstract!

The EANM annual meeting is the leading conference to network and discuss the newest trends and findings in the field of Nuclear Medicine.

EANM’2018– 13-17 Octobre – Düsseldorf – Allemagne


Oncodesign is proud to be part of this key scientific where our clinical results will be disclosed for the 1st time during a congress. 

Come & meet Cyril Berthet during the talk given by Prof. Cochet that will detail first-in-human evaluation of a new PET tracer as a marker of EGFR activating mutations in NSCLC.

TALK – “Phase 0/1 of PET imaging agent [18F]-OD2004436 as a marker of EGFR mutation in patients with non small cell lung cancer”
Pr. Alexandre Cochet, Head of Nuclear Medicine Dpt, CGFL

Date & Time: Tuesday, October 16, 2018, 11:30 am – 1:00pm
Session Hall : Hall 4

This email address is being protected from spambots. You need JavaScript enabled to view it.

A symposium on Medicinal Chemistry dedicated to drug discovery advances in major therapeutic areas.

EFMC-ISMC 2018 -  2-6 Septembre – Ljubljana -  Slovenie

EFMC-ISMC 2018 - 2-6 September – Ljubljana - Slovenia

Macrocycles have been emerging as a valuable class of pharmacological agents over the past decade.
The number of reports of innovative macrocycles in preclinical research is continuously increasing in literature.

At Oncodesign, macrocyclisation is systematically applied within all projects leading to a Nanocyclix® platform.

Come to see our poster at the XXV EFMC International Symposium on Medicinal Chemistry :
“Nanocyclix®: Next Generation Kinase Inhibitors for Probe based Drug Discovery”
Presented by Petra Blom, PhD, Drug Discovery Program Director, Oncodesign

I read the abstract

By closing this message, you consent to our cookies on this device in accordance with our cookie policy unless you have disabled them.